Clin2
NCT04539951Possibly a fitRecruiting

Trial for newly treated obsessive-compulsive disorder

Obsessive-Compulsive Disorder

Treatments studied

Part of Mental health clinical trials.

This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
1,600 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have a main diagnosis of obsessive-compulsive disorder (OCD) based on DSM-5 criteria
  • You are between 18 and 65 years old
  • Your OCD symptoms are at least moderate (Yale-Brown OCD Scale score of 20 or higher)
  • You have not taken OCD medications before, and you have not had OCD psychotherapy in the last month
  • You can provide written informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07111988Not yet recruiting· Phase 2
Valbenazine for obsessive-compulsive disorder

This study tests whether a medication called valbenazine can help reduce symptoms of moderate to severe OCD in adults. If you have OCD and are not currently changing your treatment, you may be able to join and see if this new approach works for you.

NCT04131829Recruiting· Phase 1/Phase 2
Brain scan study to predict fluoxetine response in OCD

This study looks at how brain networks change before and after starting fluoxetine (an SSRI antidepressant) in people with obsessive-compulsive disorder (OCD). It also compares these brain scan patterns with people without OCD to help predict who may respond to treatment.

New Haven, Connecticut
NCT04882839Recruiting· Phase 2
Therapy with psilocybin for severe OCD symptoms

This Phase 2 study tests whether psilocybin-assisted psychotherapy can reduce symptoms in adults with severe, treatment-resistant OCD. It also focuses on safety and whether this approach is practical to run.

Beersheba
NCT05609916Recruiting
CBT therapy to help kids stop OCD medicine

This trial studies whether adding structured talk therapy (CBT) can help some children with obsessive-compulsive disorder (OCD) reduce and potentially stop their OCD medicine. It’s designed for kids who are still having meaningful symptoms despite being on an OCD medication long enough.

Houston, Texas
NCT06992999Not yet recruiting· Phase 1/Phase 2
Psilocybin for treating OCD

This study tests if a single dose of psilocybin, a psychedelic substance, can safely help people with obsessive-compulsive disorder (OCD) who have not responded well to standard treatments. If you have moderate to severe OCD and have tried at least one recommended treatment without success, you may be able to join.

Tucson, Arizona
NCT06318806Recruiting
OCD recovery study: therapy for full remission

This study tests a psychological treatment aimed at helping people with obsessive-compulsive disorder (OCD) reach full recovery. It is done remotely using your computer or phone, so you can participate from home.

Montreal, Quebec

Hear when a new Obsessive-Compulsive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.